| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 102,912 | 147,024 | ||
| Short-term investments | 696,131 | 639,472 | ||
| Prepaid expenses and other current assets | 14,979 | 12,802 | ||
| Total current assets | 814,022 | 799,298 | ||
| Property and equipment, net | 4,675 | 3,459 | ||
| Operating right-of-use assets | 6,863 | 7,484 | ||
| Other non-current assets | 6,599 | 6,202 | ||
| Total assets | 832,159 | 816,443 | ||
| Accounts payable | 17,796 | 8,990 | ||
| Accrued expenses and other current liabilities | 36,929 | 27,379 | ||
| Operating lease liabilities, current portion | 2,802 | 2,664 | ||
| Total current liabilities | 57,527 | 39,033 | ||
| Operating lease liabilities, net of current portion | 4,288 | 5,012 | ||
| Other non-current liabilities | 325 | 317 | ||
| Total liabilities | 62,140 | 44,362 | ||
| Ordinary shares - 0.0001 par value 500,000 shares authorized as of september 30, 2025 and december 31, 2024 182,033 and 171,860 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 18 | 17 | ||
| Additional paid-in capital | 1,272,480 | 1,209,294 | ||
| Accumulated other comprehensive income | 825 | 362 | ||
| Accumulated deficit | -503,304 | -437,592 | ||
| Total shareholders' equity | 770,019 | 772,081 | ||
| Total liabilities and shareholders' equity | 832,159 | 816,443 | ||
Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR)